[NEW LAUNCH] Key Antigens & Antibody Solutions for Nipah Virus Research

영사이언스
2026-03-17

Nipah virus (NiV) is a highly lethal zoonotic pathogen with a mortality rate of 40–75%. Due to the absence of approved vaccines or therapeutics, it has been designated as a WHO Priority Pathogen.

Recently, an outbreak of the Bangladesh lineage (NiV-B)—known for higher pathogenicity—was reported in West Bengal, India, further accelerating the demand for reliable research reagents for vaccine and diagnostic development.

 


 

Key Solutions for Nipah Virus Research

Sino Biological provides a one-stop portfolio of essential antigens and antibodies required for NiV research.

NiV-G Protein – receptor binding studies and neutralizing antibody screening
NiV-F Protein – viral fusion mechanism and vaccine antigen research
Detection Antibodies – for diagnostic kit development and analytical applications

 


 

Expanded Portfolio (Coming Soon)

Additional proteins for vaccine and diagnostic research are currently under development.

NiV-N Protein – serological diagnostics and antibody detection
Pre-F Trimer – next-generation vaccine antigen
Post-F Trimer – structural comparison and immune response analysis

 


 

The Choice for Vaccine Research: ProPure Endotoxin-Free Protein

✔ Strict endotoxin control
✔ Ready for direct use in animal immunization studies
✔ Improved reproducibility in preclinical research

Premium-grade proteins optimized for vaccine and diagnostic research

 


 

If you have any questions about Sino Biological products,
please feel free to contact YoungScience Co., Ltd.